These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 7724358

  • 1. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG, Farahati J, Bier D, Knust EJ, Reiners C.
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [Abstract] [Full Text] [Related]

  • 2. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
    Celentano L, Sullo P, Klain M, Lupoli G, Cascone E, Salvatore M.
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
    [Abstract] [Full Text] [Related]

  • 3. Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
    Rufini V, Salvatori M, Saletnich I, Valenza V, Maussier ML, Martino G, Corsello SM, Pantusa M, Casolo A, Troncone L.
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):140-4. PubMed ID: 9002774
    [Abstract] [Full Text] [Related]

  • 4. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
    Kurtaran A, Scheuba C, Kaserer K, Schima W, Czerny C, Angelberger P, Niederle B, Virgolini I.
    J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
    [Abstract] [Full Text] [Related]

  • 5. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings.
    Adams S, Baum RP, Hertel A, Schumm-Draeger PM, Usadel KH, Hör G.
    Eur J Nucl Med; 1998 Sep; 25(9):1277-83. PubMed ID: 9724377
    [Abstract] [Full Text] [Related]

  • 6. [Pre- and intraoperative localization of neuroendocrine tumors].
    Adams S, Baum RP, Adams M, Wenisch H, Schumm-Draeger PM, Encke A, Usadel KH, Hör G.
    Acta Med Austriaca; 1997 Sep; 24(2):81-6. PubMed ID: 9273812
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC).
    Kurtaran A, Leimer M, Kaserer K, Yang Q, Angelberger P, Niederle B, Virgolini I.
    Nucl Med Biol; 1996 May; 23(4):503-7. PubMed ID: 8832707
    [Abstract] [Full Text] [Related]

  • 15. Localization of metastatic gastroenteropancreatic tumours by somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-octreotide.
    Hammond PJ, Arka A, Peters AM, Bloom SR, Gilbey SG.
    Q J Med; 1994 Feb; 87(2):83-8. PubMed ID: 8153292
    [Abstract] [Full Text] [Related]

  • 16. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.
    Adams S, Baum R, Rink T, Schumm-Dräger PM, Usadel KH, Hör G.
    Eur J Nucl Med; 1998 Jan; 25(1):79-83. PubMed ID: 9396878
    [Abstract] [Full Text] [Related]

  • 17. Intraoperative gamma probe detection of neuroendocrine tumors.
    Adams S, Baum RP, Hertel A, Wenisch HJ, Staib-Sebler E, Herrmann G, Encke A, Hör G.
    J Nucl Med; 1998 Jul; 39(7):1155-60. PubMed ID: 9669386
    [Abstract] [Full Text] [Related]

  • 18. Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery.
    Arslan N, Ilgan S, Yuksel D, Serdengecti M, Bulakbasi N, Ugur O, Ozguven MA.
    Clin Nucl Med; 2001 Aug; 26(8):683-8. PubMed ID: 11452174
    [Abstract] [Full Text] [Related]

  • 19. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J, Abós MD, Prats E, Delgado M, Razola P, García S, Gomollón F, García F.
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
    Kwekkeboom DJ, Lamberts SW, Habbema JD, Krenning EP.
    J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.